Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von HC Wainwright 

XOMA Corp. diskutieren

XOMA Corp.

WKN: A2ATUH / Symbol: XOMA / Name: XOMA / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

21,60 €
-4,42 %

XOMA Co. (NASDAQ: XOMA) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for XOMA provided by MarketBeat

XOMA Royalty (NASDAQ:XOMA) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for XOMA provided by MarketBeat

XOMA Royalty (NASDAQ:XOMA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Ratings data for XOMA provided by MarketBeat

Einschätzung Buy
Rendite (%) -5,26 %
Kursziel 38,50
Veränderung
Endet am 11.12.26

XOMA Royalty (NASDAQ:XOMA) was given a new $45.00 price target on by analysts at Leerink Partners. They now have an "outperform" rating on the stock.
Ratings data for XOMA provided by MarketBeat

XOMA Royalty (NASDAQ:XOMA) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Ratings data for XOMA provided by MarketBeat